Neutrophil extracellular trap production in patients with colorectal cancer in vitro

International Journal of Inflammation

Volumn 2017, Issue , 2017, Pages

  Richardson, J J R ^a,b   Hendrickse, C ^b   Gao Smith, F ^a   Thickett, D R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CELL FUNCTION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; EXTRACELLULAR TRAP; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LENGTH OF STAY; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 85031327350     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2017/4915062     Document Type: Article

References (58)

1. N. Borregaard, "Neutrophils, from Marrow to Microbes, " Immunity, vol. 33, no. 5, pp. 657-670, 2010.
2. J. Cools-Lartigue, J. Spicer, B. McDonald et al., "Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis, " Journal of Clinical Investigation, vol. 123, no. 8, pp. 3446-3458, 2013.
3. J. Y. Sagiv, J. Michaeli, S. Assi et al., "Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer, " Cell Reports, vol. 10, no. 4, pp. 562-573, 2015.
4. V. Brinkmann, U. Reichard, C. Goosmann et al., "Neutrophil extracellular traps kill bacteria, " Science, vol. 303, no. 5663, pp. 1532-1535, 2004.
5. T. A. Fuchs, U. Abed, C. Goosmann et al., "Novel cell death program leads to neutrophil extracellular traps, " The Journal of Cell Biology, vol. 176, no. 2, pp. 231-241, 2007.
6. C. F. Urban, D. Ermert, M. Schmid et al., "Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans, " PLoS Pathogens, vol. 5, no. 10, Article IDe1000639, 2009.
7. S. Patel, S. Kumar, A. Jyoti et al., "Nitric oxide donors release extracellular traps fromhuman neutrophils by augmenting free radical generation, " Nitric Oxide, vol. 22, no. 3, pp. 226-234, 2010.
8. K. D. Metzler, T. A. Fuchs, W. M. Nauseef et al., "Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity, " Blood, vol. 117, no. 3, pp. 953- 959, 2011.
9. B. E. Steinberg and S. Grinstein, "Unconventional roles of the NADPH oxidase: signaling, ion homeostasis, and cell death., " Science's STKE : signal transduction knowledge environment, vol. 2007, no. 379, p. pe11, 2007.
10. V. Papayannopoulos and A. Zychlinsky, "NETs: a new strategy for using old weapons, " Trends in Immunology, vol. 30, no. 11, pp. 513-521, 2009.
11. A. Hakkim, B. G. Furnrohr, K. Amann et al., "Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis, " Proceedings of theNational Academy of Sciences of the United States, vol. 107, pp. 9813-9818, 2010.
12. T. A. Fuchs, A. Brill, D. Duerschmied et al., "Extracellular DNA traps promote thrombosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 36, pp. 15880-15885, 2010.
13. K. Tillack, P. Breiden, R. Martin, and M. Sospedra, "T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses, " Journal of Immunology, vol. 188, no. 7, pp. 3150-3159, 2012.
14. S. Berger-Achituv, V. Brinkmann, U. A. Abed et al., "A proposed role for neutrophil extracellular traps in cancer immunoediting, " Frontiers in Immunology, vol. 4, article 48, 2013.
15. J. Cools-Lartigue, J. Spicer, S. Najmeh, and L. Ferri, "Neutrophil extracellular traps in cancer progression, " Cellular and Molecular Life Sciences, vol. 71, no. 21, pp. 4179-4194, 2014.
16. S. Sangaletti, C. Tripodo, C. Vitali et al., "Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma, " Cancer Discovery, vol. 4, no. 1, pp. 110-129, 2014.
17. M. Demers, D. S. Krause, D. Schatzberg et al., "Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 32, pp. 13076-13081, 2012.
18. S. J. Huh, S. Liang, A. Sharma, C. Dong, and G. P. Robertson, "Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development, " Cancer Research, vol. 70, no. 14, pp. 6071-6082, 2010.
19. B. McDonald, J. Spicer, B. Giannais, L. Fallavollita, P. Brodt, and L. E. Ferri, "Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms, " International Journal of Cancer, vol. 125, no. 6, pp. 1298-1305, 2009.
20. J.D. Spicer, B.McDonald, J. J.Cools-Lartigue et al., "Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells, " Cancer Research, vol. 72, no. 16, pp. 3919-3927, 2012.
21. S. Liang, C. Fu, D.Wagner et al., "Two-dimensional kinetics of beta 2-integrin and ICAM-1 bindings between neutrophils and melanoma cells in a shear flow, " American Journal of Physiology, vol. 294, pp. C743-C753, 2008.
22. F. Colotta, F. Re, N. Polentarutti, S. Sozzani, and A. Mantovani, "Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products, " Blood, vol. 80, pp. 2012-2020, 1992.
23. M. Phillipson and P. Kubes, "The neutrophil in vascular inflammation, " Nature Medicine, vol. 17, no. 11, pp. 1381-1390, 2011.
24. O. A. Al Obeed, K. A. Alkhayal, A. Al Sheikh et al., "Increased expression of tumor necrosis factor-is associated with advanced colorectal cancer stages, " World journal of gastroenterology, vol. 20, no. 48, pp. 18390-18396, 2014.
25. C. Gabay and I. Kushner, "Acute-phase proteins and other systemic responses to inflammation, "The New England Journal of Medicine, vol. 340, no. 6, pp. 448-454, 1999.
26. D. C. McMillan, M. M. Elahi, N. Sattar, W. J. Angerson, J. Johnstone, and C. S. McArdle, "Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer, " Nutrition and Cancer, vol. 41, no. 1-2, pp. 64-69, 2001.
27. S.D.Heys, L. G.Walker, D. J.Deehan, andO. E. Eremin, "Serum albumin: a prognostic indicator in patients with colorectal cancer, " Journal of the Royal College of Surgeons of Edinburgh, vol. 43, pp. 163-168, 1998.
28. T. Nozoe, T. Matsumata, M. Kitamura, and K. Sugimachi, "Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer, " The American Journal of Surgery, vol. 176, no. 4, pp. 335-338, 1998.
29. W. E. Longo, K. S. Virgo, F. E. Johnson et al., "Risk factors for morbidity and mortality after colectomy for colon cancer, " Diseases of the Colon & Rectum, vol. 43, pp. 83-91, 2000.
30. H. J. Nielsen, I. J. Christensen, S. Sorensen et al., "Preoperative plasma plasminogen activator inhibitor type-1 and serum Creactive protein levels in patients with colorectal cancer, " in The RANX05 Colorectal Cancer Study Group, vol. 7, pp. 617-623, Annals of Surgical Oncology, 2000.
31. D. C. McMillan, K. Canna, and C. S. McArdle, "Systemic inflammatory response predicts survival following curative resectionof colorectal cancer, " British Journal of Surgery, vol. 90, no. 2, pp. 215-219, 2003.
32. A. Riesco, "Five-year cancer cure: Relation to total amount of peripheral lymphocytes and neutrophils, " Cancer, vol. 25, no. 1, pp. 135-140, 1970.
33. H. W. Bruckner, P. T. Lavin, S. C. Plaxe, J. A. Storch, and E. M. Livstone, "Absolute Granulocyte, Lymphocyte, and Monocyte Counts: Useful Determinants of Prognosis for Patients With Metastatic Cancer of the Stomach, " JAMA: The Journal of the American Medical Association, vol. 247, no. 7, pp. 1004-1006, 1982.
34. A. Viganó, E. Bruera, G. S. Jhangri, S. C. Newman, A. L. Fields, and M. E. Suarez-Almazor, "Clinical survival predictors in patients with advanced cancer, " Archives of Internal Medicine, vol. 160, no. 6, pp. 861-868, 2000.
35. M.Maltoni, A.Caraceni, C. Brunelli et al., "Prognostic factors in advanced cancer patients: Evidence-based clinical recommendations - A study by the steering committee of the european association for palliative care, " Journal of Clinical Oncology, vol. 23, no. 25, pp. 6240-6248, 2005.
36. C. A. Hauser, M. R. Stockler, andM. H. N. Tattersall, "Prognostic factors in patients with recently diagnosed incurable cancer: A systematic review, " Supportive Care in Cancer, vol. 14, no. 10, pp. 999-1011, 2006.
37. S. R. Walsh, E. J. Cook, F. Goulder, T. A. Justin, and N. J. Keeling, "Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer, " Journal of Surgical Oncology, vol. 91, no. 3, pp. 181-184, 2005.
38. T. Kantola, K. Klintrup, J. P. Väyrynen et al., "Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma, " British Journal of Cancer, vol. 107, no. 10, pp. 1729-1736, 2012.
39. G. Guthrie and D. C. McMillan, "Comment on 'Stagedependent alterations of the serum cytokine pattern in colorectal carcinoma', " British Journal of Cancer, vol. 108, no. 9, pp. 1915- 1916, 2013.
40. C. S. D. Roxburgh and D. C. McMillan, "Role of systemic inflammatory response in predicting survival in patients with primary operable cancer, " Future Oncology, vol. 6, no. 1, pp. 149- 163, 2010.
41. E. F. Leitch, M. Chakrabarti, J. E.M. Crozier et al., "Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer, " British Journal of Cancer, vol. 97, no. 9, pp. 1266-1270, 2007.
42. J. A. Read, S. T. B. Choy, P. J. Beale, and S. J. Clarke, "Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival, " Nutrition and Cancer, vol. 55, no. 1, pp. 78-85, 2006.
43. H. Z. Malik, K. R. Prasad, K. J. Halazun et al., "Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases, " Annals of Surgery, vol. 246, no. 5, pp. 806-814, 2007.
44. M. Ishizuka, H. Nagata, K. Takagi, and K. Kubota, "Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer, " Annals of Surgery, vol. 250, no. 2, pp. 268-272, 2009.
45. R. Sharma, M. Zucknick, R. London, M. Kacevska, C. Liddle, and S. J. Clarke, "Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer, " Clinical Colorectal Cancer, vol. 7, no. 5, pp. 331-337, 2008.
46. T. Ohtsuka et al., "Infectious complications after gastric cancer surgery accelerate a rapid hepatic recurrence, " Hepato- Gastroenterology, vol. 56, no. (94-95), pp. 1277-1280, 2009.
47. K. Matsuo, C. P. Prather, E. H. Ahn et al., "Significance of perioperative infection in survival of patients with ovarian cancer, " International Journal of Gynecological Cancer, vol. 22, no. 2, pp. 245-253, 2012.
48. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A.Mantovani, "Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability, " Carcinogenesis, vol. 30, no. 7, pp. 1073-1081, 2009.
49. S. G. Farid, A. Aldouri, G. Morris-Stiff et al., "Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis, " Annals of Surgery, vol. 251, no. 1, pp. 91-100, 2010.
50. A. Andalib, A. V. Ramana-Kumar, G. Bartlett, E. L. Franco, and L. E. Ferri, "Influence of postoperative infectious complications on long-term survival of lung cancer patients: A populationbased cohort study, " Journal of Thoracic Oncology, vol. 8, no. 5, pp. 554-561, 2013.
51. R. Selvatici, S. Falzarano, A. Mollica, and S. Spisani, "Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils, " European Journal of Pharmacology, vol. 534, no. 1-3, pp. 1-11, 2006.
52. R. J. Smith, L. M. Sam et al., "Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness, " Journal of Pharmacology and Experimental Therapeutics, vol. 253, pp. 688-697, 1990.
53. Y. Azuma, K. Kosaka, and M. Kashimata, "Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP, " European Journal of Pharmacology, vol. 568, no. 1-3, pp. 260- 268, 2007.
54. C. S. Roxburgh, P. G. Horgan, and D. C. McMillan, "The perioperative immune/inflammatory insult in cancer surgery: Time for intervention?" OncoImmunology, vol. 2, no. 12, Article ID e27324, 2013.
55. C. S. D. Roxburgh and D. C. McMillan, "Cancer and systemic inflammation: treat the tumour and treat the host, " British Journal of Cancer, vol. 110, no. 6, pp. 1409-1412, 2014.
56. M. Shyamsundar, S. T. W. McKeown, C. M. O'Kane et al., "Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers, " American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 12, pp. 1107-1114, 2009.
57. O. A. Chow, M. von Köckritz-Blickwede, A. T. Bright et al., "Statins enhance formation of phagocyte extracellular traps, " Cell Host and Microbe, vol. 8, no. 5, pp. 445-454, 2010.
58. H. Greenwood, J. Patel, R.Mahida et al., "Simvastatin tomodify neutrophil function in older patients with septic pneumonia (SNOOPI): Study protocol for a randomised placebo-controlled trial, " Trials, vol. 15, no. 1, article no. 332, 2014.